Skip to content

Nuvation Bio NUVB Gross margin

Gross margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
70.5%0.0pp
Pfizer logo
PfizerPFE
73.5%+1.2pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
99.3%-0.5pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
100%+31.2pp
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
70.4%
Incyte logo
IncyteINCY
92.5%-0.2pp

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

Based on trailing twelve months.

The official record: Nuvation Bio’s 10-Q, filed November 3, 2025, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's gross margin?
Nuvation Bio (NUVB) reported gross margin of 54.3% in Q3 2025.
How has Nuvation Bio's gross margin changed year-over-year?
Nuvation Bio's gross margin increased by 267.6% year-over-year, from -32.4% to 54.3%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.